Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what’s new and what’s enough
Crossref DOI link: https://doi.org/10.1186/s40880-015-0036-4
Published Online: 2015-07-18
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Fei
Zhou, Cai-Cun
